Floatz logo

D-thioctic acid

Chronic Fatigue Syndrome

Columbia UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Fatigue Syndrome cohort.

Asset / SponsorPhaseRating
.GAMMA.-HYDROXYBUTYRATE SODIUM SALT
University of Medicine and Dentistry of New Jersey
Phase 4B
NORAMITRIPTYLINE
Duke University
Phase 2B
LIDOCAINE
Duke University
Phase 2B
17-beta-estradiol
Duke University
Phase 2B
coq10
Columbia University
Phase 2CCC

View all 11 →

Same molecule, other indications

D-thioctic acid is also rated in:

migraine disorderDormant
BB
Indicative ·
69 / 100
View asset →
Herpetic NeuralgiaDormant
BB
Indicative ·
69 / 100
View asset →
chronic progressive multiple sclerosisDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →